Miyoshi Hideyuki, Fujie Hajime, Shintani Yoshizumi, Tsutsumi Takeya, Shinzawa Seiko, Makuuchi Masatoshi, Kokudo Norihiro, Matsuura Yoshiharu, Suzuki Tetsuro, Miyamura Tatsuo, Moriya Kyoji, Koike Kazuhiko
Department of Internal Medicine, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
J Hepatol. 2005 Nov;43(5):757-63. doi: 10.1016/j.jhep.2005.03.028. Epub 2005 May 31.
BACKGROUND/AIMS: Suppressor of cytokine signaling (SOCS)-1, a negative feedback regulator of cytokine signaling pathway, also has a tumor suppressor activity, the silencing of its gene by hypermethylation is suggested to contribute to hepatocarcinogenesis. We studied the effect of the core protein of hepatitis C virus (HCV) on the expression of SOCS-1 gene.
HCV core gene transgenic mice, which develop hepatocellular carcinoma late in life, HepG2 cells expressing the core protein, and human liver tissues were analyzed.
The expression of SOCS-1 gene was significantly suppressed in the liver of core gene transgenic mice and HepG2 cells expressing the core protein, while that of SOCS-3 gene was conserved. SOCS-1 expression levels also decreased in HCV-positive human liver tissues. The core protein differentially down-regulated the expression of signal transducer and activator of transcription (STAT) target genes, but rather enhanced STAT1 and STAT3 activation after interleukin-6 stimulation in mouse liver tissues and cells.
HCV core protein down-regulates the expression of SOCS-1 gene. This is a mechanism leading to SOCS-1 silencing, an alternative to the hypermethylation of the gene; this effect of the core protein may modulate the intracellular signaling pathway, contributing to the pathogenesis in HCV infection including hepatocarcinogenesis.
背景/目的:细胞因子信号转导抑制因子(SOCS)-1是细胞因子信号通路的负反馈调节因子,也具有肿瘤抑制活性,其基因因高甲基化而沉默被认为与肝癌发生有关。我们研究了丙型肝炎病毒(HCV)核心蛋白对SOCS-1基因表达的影响。
分析了在生命后期发生肝细胞癌的HCV核心基因转基因小鼠、表达核心蛋白的HepG2细胞和人肝组织。
核心基因转基因小鼠肝脏和表达核心蛋白的HepG2细胞中,SOCS-1基因的表达显著受到抑制,而SOCS-3基因的表达则保持不变。HCV阳性人肝组织中SOCS-1的表达水平也降低。核心蛋白差异性地下调信号转导和转录激活因子(STAT)靶基因的表达,但在小鼠肝脏组织和细胞中,白细胞介素-6刺激后反而增强了STAT1和STAT3的激活。
HCV核心蛋白下调SOCS-1基因的表达。这是导致SOCS-1沉默的一种机制,是该基因高甲基化之外的另一种机制;核心蛋白的这种作用可能调节细胞内信号通路,在包括肝癌发生在内的HCV感染发病机制中发挥作用。